[{"NetIncomeLoss_1_Q2_USD":-25999000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":44897269.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":44969795.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":11273000.0,"RepaymentsOfDebtAndCapitalLeaseObligations_2_Q2_USD":5000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":594000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-10416000.0,"Depreciation_2_Q2_USD":216000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":616000.0,"AssetsCurrent_0_Q2_USD":419014000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7623283.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":720000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":598000.0,"CommonStockSharesIssued_0_Q2_shares":44667016.0,"Assets_0_Q2_USD":429368000.0,"ShareBasedCompensation_2_Q2_USD":12972000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1591000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":259000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":526000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":6222000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":11775000.0,"MarketableSecuritiesCurrent_0_Q2_USD":147298000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"ResearchAndDevelopmentExpense_2_Q2_USD":40727000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":20557000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":1984000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":584000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":105000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":218000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":88000.0,"CommonStockValue_0_Q2_USD":5000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":100292000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":76150000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-933000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":417100000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_2_Q2_USD":0.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-49807000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-25894000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":4338000.0,"OtherAssetsNoncurrent_0_Q2_USD":7517000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":269836000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1263000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":517120000.0,"Liabilities_0_Q2_USD":120171000.0,"OperatingLeaseLiability_0_Q2_USD":1725000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q2_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":244000.0,"CommonStockSharesAuthorized_0_Q2_shares":490000000.0,"OperatingIncomeLoss_1_Q2_USD":-26779000.0,"RestrictedCashNoncurrent_0_Q2_USD":140000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":86317000.0,"AmortizationOfFinancingCosts_2_Q2_USD":22000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":584000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":105000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":206000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6890000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-31837000.0,"LiabilitiesCurrent_0_Q2_USD":18769000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":58039000.0,"AccountsPayableCurrent_0_Q2_USD":7034000.0,"InterestExpense_2_Q2_USD":13000.0,"InterestExpense_1_Q2_USD":6000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1880000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":879000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":334000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":2305000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":269976000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1106000.0,"NetIncomeLoss_2_Q2_USD":-50391000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":77000.0,"CommonStockSharesOutstanding_0_Q2_shares":44667016.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-208522000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":231000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":147298000.0,"InvestmentIncomeInterest_2_Q2_USD":1906000.0,"InvestmentIncomeInterest_1_Q2_USD":698000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":429368000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":2165000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":12972000.0,"OperatingIncomeLoss_2_Q2_USD":-52502000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6890000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":462000.0,"OperatingExpenses_2_Q2_USD":52502000.0,"OperatingExpenses_1_Q2_USD":26779000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":2620000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.12,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.58,"OtherLiabilitiesNoncurrent_0_Q2_USD":276000.0,"StockholdersEquity_0_Q2_USD":309197000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":249000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":103000000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":175000.0,"Ticker":"KOD","CIK":"1468748","name":"KODIAK SCIENCES INC.","OfficialName":"Kodiak Sciences Inc Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"350038530.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]